Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B
2023 · New England Journal of Medicine · 314 citations
https://doi.org/10.1056/nejmoa2211644
G
Guy Young
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
401
Papers
13.1K
Citations
58
h-index
197
i10-index
Guy Young is an academic researcher from University of Southern California. The author has contributed to research in topics: Hemophilia Treatment and Research & Blood Coagulation and Thrombosis Mechanisms & Platelet Disorders and Treatments. The author has an h-index of 58, co-authored 341 publications.
ORCID: 0000-0001-6013-1254Papers by this author
worksChanges in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity
2015 · Journal of Thrombosis and Haemostasis · 59 citations
https://doi.org/10.1111/jth.13141
Pediatric Stroke and Methylenetetrahydrofolate Reductase Polymorphisms
2005 · Journal of Pediatric Hematology/Oncology · 47 citations
https://doi.org/10.1097/01.mph.0000188119.33452.fd
Antithrombin-lowering in hemophilia: a closer look at fitusiran
2023 · Research and Practice in Thrombosis and Haemostasis · 43 citations
https://doi.org/10.1016/j.rpth.2023.100179
Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study
2018 · Thrombosis Journal · 37 citations
https://doi.org/10.1186/s12959-018-0186-0
The Edoxaban Hokusai VTE PEDIATRICS Study: An open‐label, multicenter, randomized study of edoxaban for pediatric venous thromboembolic disease
2020 · Research and Practice in Thrombosis and Haemostasis · 32 citations
https://doi.org/10.1002/rth2.12352
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat